18 and older, any sex, with Melanoma. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants Interviewed on UVR Protection Behaviors.Primary· 1 year
To generate models explaining decision-making about four UVR protection behaviors (sunscreen use, shade-seeking, hat use, use of protective clothing) in melanoma FDRs. This was an inductive, qualitative study using an open-ended interview to accomplish the Aim. Cohort 1 was used for this Aim.
Group
Value
95% CI
Cohort 1: Phase I: 25 Melanoma FDRs
25
Phase II: 60 Melanoma FDRs
0
Cohort 1: Phase I: 25 Melanoma FDRs
0
Phase II: 60 Melanoma FDRs
59
To Examine Theory-driven Affective and Cognitive Predictors of UVR Protection Maintenance (Sunscreen Use, Shade-seeking, Hat Use, and Use of UVR Protective Clothing)Assessed in Real Time.Secondary· 1 year
To examine theory-driven affective and cognitive predictors of UVR protection maintenance (sunscreen use, shade-seeking, hat use, and use of UVR protective clothing) assessed in real time. Phase 1 was not assessed for this Outcome Measure.
Women who use sunscreen in cooler weather
Group
Value
95% CI
Cohort 1: Phase I: 25 Melanoma FDRs
0
Phase II: 60 Melanoma FDRs
9
Men who skip sunscreen in cooler weather and in shade while wearing a hat
Group
Value
95% CI
Cohort 1: Phase I: 25 Melanoma FDRs
0
Phase II: 60 Melanoma FDRs
21
Women who skip sunscreen in cooler weather and in shade while wearing a hat
Group
Value
95% CI
Cohort 1: Phase I: 25 Melanoma FDRs
0
Phase II: 60 Melanoma FDRs
23
Men who skip sunscreen on sunny days and in shade while wearing a hat
Group
Value
95% CI
Cohort 1: Phase I: 25 Melanoma FDRs
0
Phase II: 60 Melanoma FDRs
10
Sponsor's own description
The purpose of this study is to understand how people make decisions about sun protection. This study is important in helping to protect against sun exposure, since it is a main risk factor for melanoma. The investigators would like to understand the decisions people make about sun protection so that they can improve their ability to help individuals who may be at risk for melanoma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT04723498 — Problematic Use of the Internet in Child and Adolescent Psychiatry
· NA
· recruiting
Other recruiting trials for Melanoma
Currently open trials in the same condition.
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception
· recruiting
NCT07224425 — A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it
· Phase 1
· recruiting
NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr
· Phase 2
· recruiting
NCT07225036 — Promoting Immunotherapy Efficacy With Low-Dose Liver RT
· NA
· recruiting
NCT07379138 — Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improve
· NA
· recruiting
Other Memorial Sloan Kettering Cancer Center trials
Trials by the same sponsor.
NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer
· Phase 2
· recruiting
NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery
· Phase 3
· recruiting
NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer
· Phase 2
· recruiting
NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term
· Phase 2
· recruiting
NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
Last refreshed: 7 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01004952.